B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GHSR

MOLECULAR TARGET

growth hormone secretagogue receptor

UniProt: Q92847NCBI Gene: 269314 compounds

GHSR (growth hormone secretagogue receptor) is targeted by 14 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GHSR

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Substance P0.691
2Astemizole Antihistamine drug now withdrawn from0.691
3Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
4Chlorhexidine0.691
5cinacalcet0.691
6Daunorubicin0.691
7Dihydroergotamine0.691
8Fentanyl0.691
9Fluspirilene0.691
10Idarubicin0.691
11Nebivolol0.691
12Noscapine0.691
13oxatomide [Supplementary Concept] structure;0.691
14Yohimbine0.691

About GHSR as a Drug Target

GHSR (growth hormone secretagogue receptor) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 14 compounds with documented GHSR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GHSR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.